|
trial after completion of impact trial of arimidex years' adjuvant treatment for breast cancer". Lancet 365 (9453): impact trial of arimidex doi:10.1016/S0140-6736(04)17666-6. PMID 15639680.[edit] External linksArimidex.com - Information about Arimidex and breast cancer[hide]v • d • eSex hormones and related agents (primarily G03.
doi:10.1016/S0140-6736(04)17666-6. PMID 15639680.[edit] External linksArimidex.com - Information about Arimidex and breast cancer[hide]v • d • eSex hormones and related agents (primarily G03, also L02, H01C) - human impact trial of arimidex in CAPSProgestogens:(receptor) PROGESTERONE,Dienogest, Desogestrel, Drospirenone, Dydrogesterone, Ethisterone, Etonogestrel, Ethynodiol diacetate, Gestodene, Gestonorone, Levonorgestrel, Lynestrenol, Medroxyprogesterone, Megestrol, Norelgestromin, Norethisterone, Norethynodrel, Norgestimate, Norgestrel, Norgestrienone, TiboloneSelective progesterone receptor modulator: Afimoxifene, Bazedoxifene, Clomifene, Fulvestrant, Lasofoxifene, Raloxifene, Tamoxifen, ToremifeneAromatase impact trial of arimidex Aminogluthetimide, Anastrozole, Exemestane, Formestane, Letrozole, VorozoleGonadotropins:(FSHR/LHCGR) impact trial of arimidex stim.: Clomifene, UrofollitropinAntigonadotropins: Danazol, GestrinoneGnRH:(receptor) agonist: Buserelin, Goserelin, Histrelin, Leuprorelin, Nafarelin, Triptorelinantagonist.
women with localized breast cancer that is estrogen receptor modulator: Afimoxifene, Bazedoxifene, Clomifene, Fulvestrant.
|
__________________
http://shop-med.org pharma shop
To whom is the link to the impact trial of arimidex necessary?